Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cure Addiction Now (CAN) is a 501(c)(3) non-profit organization dedicated to funding and promoting scientific research to find a cure for substance use disorders (SUD). Founded by philanthropist Nancy Davis, the foundation aims to shift the treatment paradigm of addiction from behavioral-only approaches to include biological and medical solutions. CAN collaborates with prestigious academic institutions, such as UCLA, to support research into the neurological and physiological causes of addiction. By funding early-stage studies and clinical trials, the organization works to identify new therapeutic targets and develop effective medications for dependency. Their mission is to provide hope and evidence-based treatments for individuals and families affected by the addiction crisis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cure Addiction Now.